ADA Scientific Sessions 2025 Abstract·13 JunMazdutide, a Dual GLP-1R/GCGR Agonist, Reduces Hyperuricemia by Modulating Energy and Lipid Metabolism and Inhibiting Hepatic Purine MetabolismExperiments in animalsInterventionsPaper